Show simple item record

dc.contributor.authorTAJBER, LIDIAen
dc.contributor.authorSANTOS-MARTINEZ, MARIAen
dc.contributor.authorMEDINA MARTIN, CARLOSen
dc.contributor.authorCORRIGAN, OWENen
dc.date.accessioned2015-12-02T10:15:30Z
dc.date.available2015-12-02T10:15:30Z
dc.date.issued2014en
dc.date.submitted2014en
dc.identifier.citationUmerska A, Paluch KJ, Santos-Martinez MJ, Corrigan OI, Medina C, Tajber L, Self-assembled hyaluronate/protamine polyelectrolyte nanoplexes: synthesis, stability, biocompatibility and potential use as peptide carriers, Journal of Biomedical Nanotechnology, 10, 12, 2014, 3658 - 3673en
dc.identifier.otherYen
dc.descriptionPUBLISHEDen
dc.description.abstractThis work investigates a new type of polyelectrolyte complex nanocarrier composed of hyaluronic acid (HA) and protamine (PROT). Small (approximately 60 nm) and negatively charged nanoparticles (NPs) with a polydispersity index of less than 0.2 were obtained with properties that were dependent on the mixing ratio, concentration of polyelectrolytes and molecular weight of HA. Salmon calcitonin (sCT) was efficiently (up to 100%) associated with the NPs, and the drug loading (9.6-39% w/w) was notably high, possibly due to an interaction between HA and sCT. The NPs released -70-80% of the sCT after 24 hours, with the estimated total amount of released sCT depending on the amount of HA and PROT present in the NPs. The isoelectric point of the NPs was close to pH 2, and the negative surface charge was maintained above this pH. The HA/PROT nanoplexes protected the sCT from enzymatic degradation and showed low toxicity to intestinal epithelial cells, and thus may be a promising oral delivery system for peptides.en
dc.format.extent3658en
dc.format.extent3673en
dc.language.isoenen
dc.relation.ispartofseriesJournal of Biomedical Nanotechnologyen
dc.relation.ispartofseries10en
dc.relation.ispartofseries12en
dc.rightsYen
dc.titleSelf-assembled hyaluronate/protamine polyelectrolyte nanoplexes: synthesis, stability, biocompatibility and potential use as peptide carriersen
dc.typeJournal Articleen
dc.type.supercollectionscholarly_publicationsen
dc.type.supercollectionrefereed_publicationsen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/ltajberen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/ocorrignen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/santosmmen
dc.identifier.peoplefinderurlhttp://people.tcd.ie/martinc2en
dc.identifier.rssinternalid99251en
dc.identifier.doihttp://dx.doi.org/10.1166/jbn.2014.1878en
dc.rights.ecaccessrightsopenAccess
dc.subject.TCDThemeImmunology, Inflammation & Infectionen
dc.subject.TCDThemeNanoscience & Materialsen
dc.subject.TCDTagBiomedical applications of nanotechnologyen
dc.subject.TCDTagDRUG DELIVERY SYSTEMSen
dc.subject.TCDTagNanotechnologyen
dc.subject.TCDTagPharmacyen
dc.identifier.orcid_id0000-0003-1544-6796en
dc.contributor.sponsorScience Foundation Ireland (SFI)en
dc.contributor.sponsorGrantNumber07/SRC/B1158en
dc.contributor.sponsorScience Foundation Ireland (SFI)en
dc.contributor.sponsorGrantNumber07/SRC/B1154en
dc.contributor.sponsorHigher Education Authority (HEA)en
dc.identifier.urihttp://hdl.handle.net/2262/74990


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record